A Single-Center's Early Surgical Outcomes of Living Donor Liver Transplantation.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 03 12 2022
revised: 06 01 2023
accepted: 14 03 2023
medline: 3 7 2023
pubmed: 1 5 2023
entrez: 30 4 2023
Statut: ppublish

Résumé

Living donor liver transplantation (LDLT) has become an increasingly common surgical option because the number of cadaveric donors is insufficient to fulfill the organ needs of patients facing end-stage cirrhosis. Many centers are investigating different surgical techniques to achieve lower complication rates. We aimed to examine our complication rates in light of demographic data, graft data, and perioperative findings as a single-center experience. The study included one hundred and three patients who underwent LDLT for end-stage liver cirrhosis. Demographic data; sex; age; blood group; Model for End-Stage Liver Disease score; Child score; etiology; liver side; graft-to-recipient weight ratio; hepatic artery, portal vein, and bile anastomosis type rates; anhepatic phase; cold ischemia time; operation time; and blood product transfusion rates were analyzed. Biliary complications in patients with single or multiple biliary anastomoses, right or left liver transplants, and with or without hepatic artery thrombosis were analyzed statistically. There was no significant difference in biliary complications between patients who underwent single or multiple bile anastomosis (P = .231) or patients receiving right lobe and left lobe transplants (P = .315). Although there was no statistically significant difference in the rate of portal vein thrombosis between the regular and reconstructed portal vein anastomosis groups (P = .693), the postoperative portal vein thrombosis rate was statistically higher in patients with left lobe transplants (P = .044). Vascular and biliary complication rates can be reduced with increasing experience.

Sections du résumé

BACKGROUND BACKGROUND
Living donor liver transplantation (LDLT) has become an increasingly common surgical option because the number of cadaveric donors is insufficient to fulfill the organ needs of patients facing end-stage cirrhosis. Many centers are investigating different surgical techniques to achieve lower complication rates. We aimed to examine our complication rates in light of demographic data, graft data, and perioperative findings as a single-center experience.
METHODS METHODS
The study included one hundred and three patients who underwent LDLT for end-stage liver cirrhosis. Demographic data; sex; age; blood group; Model for End-Stage Liver Disease score; Child score; etiology; liver side; graft-to-recipient weight ratio; hepatic artery, portal vein, and bile anastomosis type rates; anhepatic phase; cold ischemia time; operation time; and blood product transfusion rates were analyzed. Biliary complications in patients with single or multiple biliary anastomoses, right or left liver transplants, and with or without hepatic artery thrombosis were analyzed statistically.
RESULTS RESULTS
There was no significant difference in biliary complications between patients who underwent single or multiple bile anastomosis (P = .231) or patients receiving right lobe and left lobe transplants (P = .315). Although there was no statistically significant difference in the rate of portal vein thrombosis between the regular and reconstructed portal vein anastomosis groups (P = .693), the postoperative portal vein thrombosis rate was statistically higher in patients with left lobe transplants (P = .044).
CONCLUSIONS CONCLUSIONS
Vascular and biliary complication rates can be reduced with increasing experience.

Identifiants

pubmed: 37121859
pii: S0041-1345(23)00156-2
doi: 10.1016/j.transproceed.2023.03.028
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1209-1213

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

DISCLOSURES The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Ender Anılır (E)

Organ Transplantation Center, İstanbul Aydın University Medikalpark Florya Hospital, Istanbul, Turkey. Electronic address: dr.enderanilir@gmail.com.

Alihan Oral (A)

Internal Medicine Department, Fenerbahce University Medicana Hospital, Istanbul, Turkey.

Alp Atasoy (A)

Gastroenterology Department, İstanbul Aydın University Medikalpark Florya Hospital, Istanbul, Turkey.

Hasret Ayyıldız Civan (HA)

Pediatric Gastroenterology Department, İstanbul Aydın University Medikalpark Florya Hospital, Istanbul, Turkey.

Feyza Sönmez Topçu (FS)

Radiology Department, İstanbul Aydın University Medikalpark Florya Hospital, Istanbul, Turkey.

Mert Bayramoğlu (M)

Radiology Department, İstanbul Aydın University Medikalpark Florya Hospital, Istanbul, Turkey.

Emrah Şahin (E)

Organ Transplantation Center, İstanbul Aydın University Medikalpark Florya Hospital, Istanbul, Turkey.

Abuzer Dirican (A)

Organ Transplantation Center, İstanbul Aydın University Medikalpark Florya Hospital, Istanbul, Turkey.

Bülent Ünal (B)

Organ Transplantation Center, İstanbul Aydın University Medikalpark Florya Hospital, Istanbul, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH